Astrazeneca PLC/ US0463531089 /
2024-04-19 4:35:36 PM | Chg. +0.17 | Volume | Bid4:35:37 PM | Ask4:35:37 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
68.53USD | +0.24% | 41,793 Turnover: 2.86 mill. |
68.52Bid Size: 300 | 68.54Ask Size: 200 | 209.96 bill.USD | - | 17.83 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 3.84 USD | 81.13% |
EPS Diluted: | - USD | - |
Revenues per Share: | - USD | - |
Book Value per Share: | - USD | - |
Cash Flow per Share: | - USD | - |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 45,811.00 USD | 3.29% |
Net Income: | 5,955.00 USD | 84.48% |
Operating Cash Flow: | 10,345.00 USD | - |
Cash and Cash Equivalents: | 5,840.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 17.83 | - |
P/S Ratio: | - | - |
P/BV ratio: | - | - |
P/CF Ratio: | - | - |
PEG: | 0.22 | - |
Earnings Yield: | 5.61% | - |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 209.96 bill. USD | 209.27 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 3.1 bill. |
Profitability
Gross Profit Margin: | 81.95% |
EBIT Margin: | 17.88% |
Net Profit Margin: | 13.00% |
Return on Equity: | 15.21% |
Return on Assets: | 5.89% |
Financial Strength
Liquidity I / Cash Ratio: | 19.12% |
Liquidity II / Quick Ratio: | 58.82% |
Liquidity III / Current Ratio: | 82.03% |
Debt / Equity Ratio: | 158.33% |
Dynam. Debt / Equity Ratio: | 599.09% |
Efficiency
Employees: | 89,900 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 509,577.31 USD |
Net Income / Employee: | 66,240.27 USD |
Total Assets / Employee: | 1,124,794.22 USD |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | USD |